All In MedTech

Device Trial Radar · NCT05881655

Slow Myopia Progression With Different Irradiance Light

A Prospective Clinical Trial on Slow Myopia Progression With Two Different Irradiance Light at Baseline and Dynamic Changes at Follow-up

Last checked: Nov 20, 2026Latest source record: May 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

75

Planned (sponsor's estimate)

Start

May 20, 2023

Primary completion

May 30, 2024

Study completion Dec 30, 2025

Sponsor

Lead sponsor
Beijing Airdoc Technology Co., Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
Shanghai Children's Medical Center
First posted
May 31, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 6 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

It is a prospective clinical control study on red light control myopia with specail design spectacles for 75 children in 3 groups. Study Groups with two different powers of 0.6 mW and 1.2 mW at wavelength of 650nm. The control group is to wear the same brand and design spectalces as those two study groups. In addition, the progression of myopia is usually accompanied by the changes in a variety of ocular parameters, such as refractive error, reduced submacular choroidal thickness, and prolonged length of the ocular axis length.The goal is to test which power (1.2mW and 0.6mW) is better in myopic children for 3 month's follow-up and also to test how to get better result with the increaing or decreasing lighting power for the total 6 month follow-up results .

Conditions

  • Myopia, Progressive

Interventions

  • Airdoc Red Lighting DeviceDevice

    A medical device with ultra low lever laser irradiance of 0.6mW or 1.2mW at the surface of cornea. And the therapy lasts 3 minutes with the 4 hours or more interval of break.

  • Special Spectacles to Control MyopiaDevice

    Customer designed power and fitting to each subject for all the study periods.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change of Ocular Axial length elongation at follow-up from Baseline (mm)Time frame: 3-month
  2. Mean Change of Ocular Axial length elongation at follow-up from Baseline (mm)Time frame: 6-month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Children Medical Center

    Shanghai, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.